Form 4: Sabra Health Care REIT Director Lynne Katzmann Receives Equity Grant

Sabra Health Care REIT, Inc. Director Lynne S. Katzmann was granted 8,178 restricted stock units, increasing her beneficial ownership to 74,592 shares.

Summary

• Lynne S. Katzmann, a Director of Sabra Health Care REIT, Inc. (SBRA), was granted 8,178 shares of common stock in the form of restricted stock units (RSUs).
• The transaction occurred on June 12, 2025, with a price of $0 per unit, indicating a grant rather than a purchase.
• These RSUs will vest in equal monthly installments starting July 12, 2025, and concluding on the earlier of June 12, 2026, or the day before the next annual stockholders' meeting.
• Following this transaction, Ms. Katzmann's total beneficial ownership in Sabra Health Care REIT, Inc. stands at 74,592 shares, which includes the newly granted 8,178 unvested RSUs and 43,619 stock units that have vested but whose payment has been deferred.

Sentiment

Score: 7

Explanation: The sentiment is positive as it represents a routine equity grant to a director, which aligns their interests with shareholders and is a standard compensation practice. It does not indicate any negative operational or financial news.

Positives

• The grant of restricted stock units to Director Lynne S. Katzmann aligns her interests with those of the shareholders, as her compensation is tied to the company's future performance.
• This is a standard form of equity compensation, indicating ongoing commitment from the board.

Risks

• The document, being a Form 4, does not detail company-specific risks. The primary risk related to this transaction is the potential for the value of the restricted stock units to decrease if the company's stock price declines before or after vesting.

Future Outlook

This Form 4 filing is a disclosure of an insider transaction and does not contain forward-looking statements or guidance regarding the company's future performance or strategic outlook beyond the vesting schedule of the granted equity.

Industry Context

The grant of restricted stock units to a director is a common practice in the real estate investment trust (REIT) sector, as well as across various industries, to incentivize long-term performance and align management and board interests with shareholder value. This transaction is consistent with typical corporate governance and compensation practices.

Comparison to Industry Standards

• This equity grant is a standard form of director compensation, aligning with common practices across publicly traded companies, including those in the healthcare REIT sector. It is not a performance metric or project result that can be directly compared to specific companies or projects like financial results would be.

Corporate Governance

Related Party Transactions

• Director Lynne S. Katzmann, a related party, received a grant of 8,178 restricted stock units as part of her compensation under the company's 2009 Performance Incentive Plan.

Stakeholder Impact

• Shareholders: The equity grant aligns the director's financial interests with the long-term performance of the company, potentially benefiting shareholders through improved governance and strategic decisions.
• Employees: No direct impact on employees is indicated by this filing.
• Customers: No direct impact on customers is indicated by this filing.
• Suppliers: No direct impact on suppliers is indicated by this filing.
• Creditors: No direct impact on creditors is indicated by this filing.

Next Steps

• The granted restricted stock units will vest in equal monthly installments beginning July 12, 2025, and concluding on the earlier of June 12, 2026, or the day before the next annual stockholders' meeting.

Key Dates

Keywords

Sabra Health Care REIT, SBRA, Form 4, Insider Transaction, Restricted Stock Units, Equity Grant, Director Compensation, Beneficial Ownership